Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

LLS Valvoline

Valvoline™ Global Operations Announces Major Commitment to The Leukemia & Lymphoma Society to Power Better Treatments for Kids with Blood Cancer Worldwide

September 11, 2024

Light The Night

Skies Across North America to Light Up This Fall in Support of Blood Cancer Patients

September 3, 2024

Visionaries of the Year

Leukemia Survivor Named National ‘Visionary of the Year’ Redefining What’s Possible After Diagnosis

July 18, 2024

LLS Research Grantees

The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care

July 10, 2024

Scenic Shore

Cycling Enthusiasts to Embark on One-of-a-Kind Adventure to Support Blood Cancer Patients Nationwide

July 8, 2024

Image of text that reads "Breaking News" over lymphoma cells.

FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma

June 27, 2024

high school students at celebration event

14-Year-Old High School Students from Los Angeles Earn The Leukemia & Lymphoma Society’s (LLS) 2024 National Student Visionaries of the Year Title

June 27, 2024

AJAY_KATARIA_BARCLAYS_AWARD

Barclays Ajay Kataria is on a Mission to End Blood Cancer

June 26, 2024

Image of text that reads "Breaking News" over leukemia cells

FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia

June 18, 2024

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.